Skip to main content

Table 2 The distrubitions of CYP2D6*2, CYP2D6*3, CYP2D6*4 and CYP2D6 *10 alleles in patient and control group

From: Diltiazem efficacy and CYP2D6 gene polymorphism in patients with atrial fibrillation with rapid ventricular response

 

Patient cohort (%)

Control cohort (%)

Total (%)

 

CYP2D6*2

    

 wt/wt

56 (39.4)

86 (60.6)

142 (100)

p = 0.001

 wt/*2

31 (68.9)

14 (31.1)

45 (100)

 *2/*2

0 (0)

0 (0)

0 (0)

CYP2D6*3

    

 wt/wt

61 (44.9)

75 (55.1)

136 (100)

p = 0.454

 wt/*3

26 (51)

25 (49)

51 (100)

 *3/*3

0 (0)

0 (0)

0 (0)

CYP2D6*4

    

 wt/wt

62 (42.8)

83 (57.2)

145 (100)

p = 0.055

 wt/*4

25 (59.5)

17 (40.5)

42 (100)

 *4/*4

0 (0)

0 (0)

0 (0)

CYP2D6*10

    

 wt/wt

78 (53.4)

68 (46.6)

146 (100)

p = 0.0001

 wt/*10

9 (22)

32 (78)

41(100)

 *10/*10

0 (0)

0 (0)

0 (0)

  1. Bold values indicate p < 0.05 which is statistically significant
  2. p* values derived from Pearson Chi-square test
  3. p** values derived from Fisher's exact chi-square test